Danielle Brander is a Hematologist Oncology specialist and a Hematologist in Durham, North Carolina. Dr. Brander is rated as an Advanced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). Her top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Small Lymphocytic Lymphoma (SLL), Leukemia, and Bone Marrow Aspiration. Dr. Brander is currently accepting new patients.

Murat Arcasoy is a Hematologist Oncology specialist and a Hematologist in Durham, North Carolina. Dr. Arcasoy is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Essential Thrombocythemia, Polycythemia Vera, Myelofibrosis, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Bone Marrow Aspiration. Dr. Arcasoy is currently accepting new patients.

Robin Hardie is a Hematologist Oncology specialist and a Hematologist in Durham, North Carolina. Dr. Hardie has been practicing medicine for over 27 years and is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). Her top areas of expertise are Paget Disease of the Breast, Monoclonal Gammopathy of Undetermined Significance (MGUS), Familial Colorectal Cancer, and Colorectal Cancer.

I treat patients with blood disorders and cancers, and I have a particular interest in helping patients with hematologic blood cancers, like leukemia, myeloma, and lymphoma, including the use of cellular therapies. I am fortunate to have a great team that works with me. We emphasize providing compassionate, individualized care using up-to-date, evidence-based treatments, including access to clinical trials. My patients are often going through a great deal, and I am devoted to their care. I have lived in this community for several decades and am honored to practice here. Dr. Ramalingam is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Monoclonal Gammopathy of Undetermined Significance (MGUS), Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma, Schnitzler Syndrome, and Bone Marrow Transplant.

Since studying basic immunology prior to beginning my clinical training, I have been deeply interested in applying immunological perspective for the treatment of cancers including hematologic malignancies. Interestingly emerging immunotherapies showed very promising results in recent years. In my clinic, I treat patients with multiple myeloma which is one type of cancer arising from plasma cells. My research will focus on developing early phase clinical protocols utilizing novel cellular therapy approach and also improving the outcomes of blood and marrow transplantation. My ultimate goal is to provide better treatment options than the current standard approach to patients. Dr. Choi is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Bone Marrow Transplant, and Bone Marrow Aspiration.

The Division of Cellular Therapy does bone marrow transplants and stem cell transplants for patients with different types of blood cancers. Specifically, I see patients with multiple myeloma or other plasma cell issues like amyloidosis. Many of the cases in my clinic are difficult. So I spend a lot of time talking with my patients, explaining the disease when they come as new patients and talking about the complexity of the disease, because it’s important that they understand what to ask their physicians here at Duke and at home. There’s no standard treatment for myeloma. We have different options – continuation of therapy, immediate transplant or transplant later. I like to explain to patients why I favor a certain treatment approach and why I think it would be the best approach for them. Dr. Gasparetto is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). Her top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Colonoscopy.

Sascha Tuchman is a Hematologist and an Oncologist in Chapel Hill, North Carolina. Dr. Tuchman is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Monoclonal Gammopathy of Undetermined Significance (MGUS), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Tuchman is currently accepting new patients.

I primarily see patients who have a variety of rare bleeding and clotting disorders. I see both older and younger patients and also provide help when patients need to transition to and away from blood thinners. Doctors usually refer patients to me. I try to work with each patient so they understand why they are seeing me and what is going on with their body. I enjoy when a patient can leave my office with a complete understanding of what is going on and what they need to do to get better. As a young child, I had bad allergies and spent much time in the doctor’s office. As a frequent patient, I enjoyed spending time around medicine. As I entered college, I found that I enjoyed chemistry and that hematology allowed me to combine lab work with patient care. Dr. Ortel is rated as an Advanced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Venous Thromboembolism (VTE), Antiphospholipid Syndrome, Thrombocytopenia, Deep Vein Thrombosis, and Thalamotomy.

Gowthami Arepally is a Hematologist in Durham, North Carolina. Dr. Arepally has been practicing medicine for over 36 years and is rated as an Advanced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). Her top areas of expertise are Thrombocytopenia, Adult Immune Thrombocytopenia, Sickle Cell Disease, and Immune Thrombocytopenic Purpura (ITP).

What makes Duke Health unique in bone marrow transplants is its holistic approach. We take care of the disease -- which is important, because these are very serious, potentially fatal diseases. But at the same time, we pay attention to patients’ emotional and psychological well-being in addition to their physical well-being. And not only for patients but also the whole family, because the caregivers and other parts of the family need attention as well. I wanted to go into medicine, because it was a great way to interact and take care of patients. In my mind, cancer is one of two diseases within internal medicine where you can actually cure people. The best part of bone marrow transplant is that the time between the laboratory and the patient is short. Patients who need a transplant tend to be relatively sick and in need of new therapies. That’s been very intellectually challenging and fun. Dr. Chao is rated as an Advanced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), Multiple Myeloma, Bone Marrow Transplant, and Bone Graft.

As a physician and scientist, my ultimate goal is to translate research findings from bench to beside to improve patient care. I focus my research and clinical work on treating blood and bone marrow cancers. Most of the patients in my clinic are blood and bone marrow transplant patients and patients with plasma cell diseases such as multiple myeloma, amyloidosis, POEMS syndrome, and Waldenstrom's macroglobulinemia. The research interests in my lab are on the development of new approaches to enhance hematopoietic stem cell engraftment and reconstitution following blood and bone marrow transplant. Dr. Kang is rated as an Advanced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Schnitzler Syndrome, Bone Marrow Aspiration, and Bone Graft.

Richard Lopez is a Transplant Surgeon in Durham, North Carolina. Dr. Lopez has been practicing medicine for over 36 years and is rated as an Advanced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Multiple Myeloma, Acute Myeloid Leukemia (AML), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.

An interest in biological sciences and giving back to the community drove me to medical school, but it has been a desire to advance the field of hematologic malignancies, specifically Multiple Myeloma, that brings me to Duke Health. Cancer is a life-altering diagnosis. With a strong, competent team caring for a patient, there can be many success stories. My goal is to empower my patients to understand their diagnosis and how to manage their disease while providing them with many treatment options along the way. Dr. Costa is rated as an Advanced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). Her top areas of expertise are Relapsed Refractory Multiple Myeloma (RRMM), Multiple Myeloma, Smoldering Multiple Myeloma, Hereditary Cerebral Amyloid Angiopathy, and Bone Marrow Aspiration.

I study disorders of the bone marrow and bone marrow failure syndromes. I also see some leukemias and lymphomas and other blood malignancies. Duke offers a very personalized, individualized level of care to each patient. Nobody is the same, so we take the whole patient, we listen to them, and we offer our best recommendations for treatment options. We offer some of the latest treatment options that are available, usually in the setting of a clinical trial. If not, we offer the latest advancement in the field. When I was going through medical school, molecular biology was the new field. Everything was being described as a new cancer-causing gene. And to me that was so appealing – we’re going to figure out what causes cancer and new ways to treat it. That’s what really brought me into the hematology oncology world – things were being discovered that were new and exciting and hopefully would lead to new treatment options. Duke offers an extremely high standard of care. Though we’re not always successful and the disease sometimes wins, our goal is to give the patients the best possible care. Dr. Decastro is rated as an Advanced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Paroxysmal Nocturnal Hemoglobinuria (PNH), Aplastic Anemia, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration.

I am a hematology/oncology specialist who first decided to work with cancer patients after volunteering for several years at the Duke Cancer Patient Support Program. I have a concentration in breast cancer but treat all types of cancer and blood disorders. I have been privileged to work with a very diverse, multicultural patient population from all areas of the world. I feel that it is very important to take a multidisciplinary approach to address all patient needs throughout their cancer journey. I remain deeply committed to that goal, involving their caregivers and all other team members to provide the highest level of support and patient care. I was born and raised in Brooklyn, New York and did my medical training in the Washington, D.C. region. In my free time, I enjoy being a wife and devoted mother to two sons, going to the opera, singing, traveling, and cooking. Dr. Howard is rated as an Experienced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Hemangioma Thrombocytopenia Syndrome, and Monoclonal Gammopathy of Undetermined Significance (MGUS).

Marilyn Telen is a Hematologist in Durham, North Carolina. Dr. Telen has been practicing medicine for over 52 years and is rated as an Experienced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). Her top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, and Hemolytic Anemia.

Sandy El Bitar is a Hematologist in Durham, North Carolina. Dr. El Bitar has been practicing medicine for over 12 years and is rated as an Experienced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). Her top areas of expertise are Febrile Neutropenia, Agranulocytosis, Chronic Familial Neutropenia, and Essential Thrombocythemia.

I am a medical oncologist who primarily focuses on treating breast cancer. I’ve been at Duke Raleigh since 2007, and I also serve as the hospital’s chief medical officer. My favorite part of my job is the initial patient visit. It’s not unusual for patients to arrive for their appointment feeling fearful and anxious. I enjoy making them feel more comfortable and at ease with their diagnosis and treatment plan by the end of the visit. To further build that bond and trust, I encourage my patients to have full access to me, even on weekends or holidays, so I can help guide their treatment. I decided to become a doctor when I was 18 years old and heading to college. I felt that I would be passionate about taking care of people and my intuition turned out to be right. I am married to a physician and my oldest son is a medical school graduate, so medicine is now firmly in my family’s blood. Dr. Spiritos is rated as an Experienced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Paget Disease of the Breast, Breast Cancer, Angiosarcoma, and Inflammatory Breast Cancer.

Oluwatoyosi Onwuemene is a Hematologist in Durham, North Carolina. Dr. Onwuemene has been practicing medicine for over 18 years and is rated as an Experienced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). Her top areas of expertise are Thrombocytopenia, Pulmonary Embolism, Blood Clots, Sickle Cell Disease, and Bone Marrow Aspiration.

I see patients with blood related cancers, primarily lymphoma. I provide them with comprehensive care from the time they come in for diagnosis until they are cured. Duke is special because I can bring the power of a large medical center with expertise across disciplines together for the care of each patient. One of the nicest parts of my job is the Christmas cards I receive from patients that I’ve treated. For many patients who are doing well, we discharge them from the clinic after five years. The Christmas cards give me the opportunity to see that they are getting on with their lives and to hear about how their families are doing. Outside of work, my wife and I spend a lot of our free time with our two daughters and their children. We like the beach, biking and hiking as a family. Dr. Diehl is rated as an Experienced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Diffuse Large B-Cell Lymphoma (DLBCL), Acute Myeloid Leukemia (AML), B-Cell Lymphoma, Non-Hodgkin Lymphoma, and Bone Marrow Aspiration.